Product Information
MESALAMINE DR 1.2 GM TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.8138 per EA under NDC 00904683204. Its NADAC has been published 275 times since Mar 24, 2021.
Strength
1.2 g/1
Manufacturer
Major PharmaceuticalsNDC
00904683204
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA091640On Market Since
6/19/2017
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 275 times since Mar 24, 2021, and over the history we have for it it has declined 72.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8138 per EA |
|---|---|
| All-time high | $3.3161 (Jun 16, 2021) |
| All-time low | $0.8138 (Jun 17, 2026) |
| 52-week high | $1.1318 |
| 52-week low | $0.8138 |
| Median price | $2.0207 |
| Average price | $1.9280 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 275 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by Major Pharmaceuticals, is $0.8138 per EA (NDC 00904683204), effective Jun 24, 2026.
How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 72.0%. It has been tracked across 275 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?
Since Mar 24, 2021, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.8138 (Jun 17, 2026) to a high of $3.3161 (Jun 16, 2021), with a median of $2.0207 per EA.
Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE DR 1.2 GM TABLET, but none are currently priced below it.
Who manufactures MESALAMINE DR 1.2 GM TABLET?
MESALAMINE DR 1.2 GM TABLET (NDC 00904683204) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification